LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Altimmune (NASDAQ: ALT)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
02/02/2024
Sell
$9.32
2,330
$22K
42,660
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
02/01/2024
Sell
$9.88
1,801
$18K
37,215
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
02/02/2024
Sell
$9.32
2,332
$22K
53,633
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
02/01/2024
Sell
$9.88
1,801
$18K
48,190
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
02/02/2024
Sell
$9.32
8,376
$78K
292,028
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
02/01/2024
Sell
$9.88
7,313
$72K
281,454
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
01/31/2024
Buy
$2.69
5,860
$16K
32,850
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
01/30/2024
Sell
$9.80
2,709
$27K
26,990
NASDAQ ALT Altimmune
Jordt Raymond M / officer: Chief Business Officer
01/31/2024
Buy
$2.69
5,030
$14K
13,743
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
01/31/2024
Buy
$2.69
3,257
$9K
43,825
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
01/30/2024
Sell
$9.80
2,709
$27K
40,568
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
01/31/2024
Buy
$2.69
7,889
$21K
272,222
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
01/30/2024
Sell
$9.80
11,697
$115K
264,333
NASDAQ ALT Altimmune
Eisenstadt Richard I / officer: Chief Financial Officer
01/31/2024
Buy
$2.69
4,621
$12K
45,012
NASDAQ ALT Altimmune
Eisenstadt Richard I / officer: Chief Financial Officer
01/30/2024
Sell
$9.80
2,175
$21K
40,391
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
01/25/2024
Buy
$9.28
163,200
$1.514M
163,200
NASDAQ ALT Altimmune
Jordt Raymond M / officer: Chief Business Officer
01/25/2024
Buy
$9.28
163,200
$1.514M
163,200
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
01/25/2024
Buy
$9.28
163,200
$1.514M
163,200
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
01/25/2024
Buy
$9.28
470,000
$4.362M
470,000
NASDAQ ALT Altimmune
Eisenstadt Richard I / officer: Chief Financial Officer
01/25/2024
Buy
$9.28
163,200
$1.514M
163,200
NASDAQ ALT Altimmune
Jordt Raymond M / officer: Chief Business Officer
01/01/2024
Sell
$11.25
2,503
$28K
8,704
NASDAQ ALT Altimmune
Eisenstadt Richard I / officer: Chief Financial Officer
12/29/2023
Sell
$11.25
3,044
$34K
33,291
NASDAQ ALT Altimmune
Schafer Klaus / director
09/28/2023
Buy
$2.50
26,100
$65K
26,100
NASDAQ ALT Altimmune
Drutz David / director
09/28/2023
Buy
$2.50
26,100
$65K
26,100
NASDAQ ALT Altimmune
Hodges Philip / director
09/28/2023
Buy
$2.50
26,100
$65K
26,100
NASDAQ ALT Altimmune
Sohn Catherine A. / director
09/28/2023
Buy
$2.50
26,100
$65K
26,100
NASDAQ ALT Altimmune
GILL JOHN / director
09/28/2023
Buy
$2.50
26,100
$65K
26,100
NASDAQ ALT Altimmune
SAYARE MITCHEL / director
09/28/2023
Buy
$2.50
26,100
$65K
26,100
NASDAQ ALT Altimmune
Jorkasky Diane / director
09/28/2023
Buy
$2.50
26,100
$65K
26,100
NASDAQ ALT Altimmune
Pisano Wayne / director
09/28/2023
Buy
$2.50
26,100
$65K
26,100
NASDAQ ALT Altimmune
Drutz David / director
08/15/2023
Buy
$2.88
300
$863
29,785
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
07/31/2023
Buy
$2.81
126
$354
249,255
NASDAQ ALT Altimmune
Eisenstadt Richard I / officer: Chief Financial Officer
07/31/2023
Buy
$2.81
1,825
$5K
23,835
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
07/31/2023
Buy
$2.81
691
$2K
34,002
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
07/31/2023
Buy
$2.81
568
$2K
20,424
NASDAQ ALT Altimmune
Jordt Raymond M / officer: Chief Business Officer
07/31/2023
Buy
$2.81
1,832
$5K
1,832
NASDAQ ALT Altimmune
GILL JOHN / director
08/12/2022
Sell
$15.00
2,714
$41K
2,771
NASDAQ ALT Altimmune
Drutz David / director
03/23/2023
Buy
$4.27
9,000
$38K
29,484
NASDAQ ALT Altimmune
Sohn Catherine A. / director
03/23/2023
Buy
$4.19
47,000
$197K
47,000
NASDAQ ALT Altimmune
Eisenstadt Richard I / officer: Chief Financial Officer
03/24/2023
Buy
$4.31
10,000
$43K
22,010
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
03/23/2023
Buy
$4.22
10,000
$42K
33,311
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
02/02/2023
Sell
$15.04
2,375
$36K
19,856
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
02/02/2023
Sell
$15.04
2,364
$36K
23,311
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
02/02/2023
Sell
$15.04
8,422
$127K
249,129
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
02/01/2023
Sell
$13.78
2,183
$30K
14,456
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
01/31/2023
Buy
$10.21
1,436
$15K
10,473
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
02/01/2023
Sell
$13.78
2,183
$30K
17,900
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
01/31/2023
Buy
$10.21
1,296
$13K
13,917
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
02/01/2023
Sell
$13.78
7,658
$106K
238,601
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
01/31/2023
Buy
$10.21
1,938
$20K
229,713
NASDAQ ALT Altimmune
Eisenstadt Richard I / officer: Chief Financial Officer
01/31/2023
Buy
$10.21
1,172
$12K
12,010
NASDAQ ALT Altimmune
Garg Vipin K / director, officer: President and CEO
01/30/2023
Buy
$12.88
302,900
$3.901M
302,900
NASDAQ ALT Altimmune
Roberts M Scot / officer: Chief Scientific Officer
01/30/2023
Buy
$12.88
105,000
$1.352M
105,000
NASDAQ ALT Altimmune
Eisenstadt Richard I / officer: Chief Financial Officer
01/30/2023
Buy
$12.88
105,000
$1.352M
105,000
NASDAQ ALT Altimmune
Harris Matthew Scott / officer: Chief Medical Officer
01/30/2023
Buy
$12.88
105,000
$1.352M
105,000

COPYRIGHT ©2023 HEALTH STOCKS HUB